The Heart Foundation is honored to support innovative, groundbreaking heart disease research happening at Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles, CA, under the direction of world-renowned cardiologist, Dr. P.K. Shah.
Over 120 years ago, Cedars-Sinai started as a 12-bed hospital
in Los Angeles.
Today, Cedars-Sinai is a nonprofit academic healthcare organization that serves more than 1 million people every year in over 40 locations, with more than 4,500 physicians and nurses and 1,500 research projects in motion.
>1 000 000
people served
every year
>40
locations
>4500
physicians and
nurses
>1500
research projects
in motion
#1 in California
#1 in Los Angeles
Cedars-Sinai is ranked #1 hospital in California* and #1 hospital in Los Angeles on U.S. News & World Report’s “Best Hospitals Honor Roll”, as well as among the very best in 11 specialties nationwide. Cedars-Sinai has been on the “Best Hospitals” Honor Roll for eight consecutive years.
*Tied for #1 ranking
#1 in California
#2 in the Nation
Smidt Heart Institute is ranked #1 in California and #2 in the nation for Cardiology and Heart Surgery in U.S. News & World Report’s “Best Hospitals of 2023-2024.”
Cedars-Sinai Mission Statement
Cedars-Sinai is a nonprofit, independent healthcare organization committed to improving the health status of the communities we serve through:
- Leadership and excellence in delivering quality healthcare services
- Expanding the horizons of medical knowledge through biomedical research
- Educating and training physicians and other healthcare professionals
- Improving the health status of the community
Quality patient care is our priority. Providing excellent clinical and service quality, offering compassionate care, and supporting research and medical education are essential to our mission. This mission is founded in the ethical and cultural precepts of the Judaic tradition, which inspire devotion to the art and science of healing and to the care we give our patients and staff.
The Smidt Heart Institute has produced numerous other major clinical and scientific advances over the last five years, securing more than $192 million in research funding from the National Institutes of Health, the California Institute for Regenerative Medicine, charitable foundations and other sources.
